-
Je něco špatně v tomto záznamu ?
SARS-CoV-2 vaccination in the context of original antigenic sin
M. Petráš, I. Králová Lesná
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2022
Free Medical Journals
od 2012 do Před 1 rokem
PubMed Central
od 2012 do Před 1 rokem
Europe PubMed Central
od 2012 do Před 1 rokem
Taylor & Francis Open Access
od 2022-04-01
Medline Complete (EBSCOhost)
od 2022-01-31
ROAD: Directory of Open Access Scholarly Resources
od 2012
- MeSH
- antigeny MeSH
- COVID-19 * prevence a kontrola MeSH
- lidé MeSH
- SARS-CoV-2 * MeSH
- vakcinace MeSH
- vakcíny proti COVID-19 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Immunological memory is the ability of the adaptive immune system to ensure a persistent protective effect after immunization. However, it can also be a limitation to building a sufficient level of protective antibodies specific to new mutations of the virus. It is imperative to bear this phenomenon (called "original antigenic sin") in mind and make every effort to overcome its inherent pitfalls when updating current and designing new vaccines.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010650
- 003
- CZ-PrNML
- 005
- 20220506131116.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/21645515.2021.1949953 $2 doi
- 035 __
- $a (PubMed)34242123
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Petráš, Marek $u Department of Epidemiology and Biostatistics, Charles University Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000329131736
- 245 10
- $a SARS-CoV-2 vaccination in the context of original antigenic sin / $c M. Petráš, I. Králová Lesná
- 520 9_
- $a Immunological memory is the ability of the adaptive immune system to ensure a persistent protective effect after immunization. However, it can also be a limitation to building a sufficient level of protective antibodies specific to new mutations of the virus. It is imperative to bear this phenomenon (called "original antigenic sin") in mind and make every effort to overcome its inherent pitfalls when updating current and designing new vaccines.
- 650 _2
- $a antigeny $7 D000941
- 650 12
- $a COVID-19 $x prevence a kontrola $7 D000086382
- 650 _2
- $a vakcíny proti COVID-19 $7 D000086663
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a vakcinace $7 D014611
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Králová Lesná, Ivana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Anesthesia and Intensive Medicine, First Faculty of Medicine, Charles University and University Military Hospital, Prague, Czech Republic $1 https://orcid.org/0000000290534123 $7 xx0112415
- 773 0_
- $w MED00181409 $t Human vaccines & immunotherapeutics $x 2164-554X $g Roč. 18, č. 1 (2022), s. 1949953
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34242123 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131108 $b ABA008
- 999 __
- $a ok $b bmc $g 1788701 $s 1161848
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 18 $c 1 $d 1949953 $e 20210709 $i 2164-554X $m Human vaccines & immunotherapeutics $n Hum Vaccin Immunother $x MED00181409
- LZP __
- $a Pubmed-20220425
